CM Life Sciences III Inc. (NASDAQ: CMLT) Stock Competitors & Peer Comparison
See CMLT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CMLT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CMLT | $8.69 | -5.65% | 4.2B | N/A | N/A | N/A |
| CCIV | $24.25 | +5.90% | 44.4B | N/A | N/A | N/A |
| PSACU | $17.08 | +0.35% | 12B | -108.79 | -$0.16 | N/A |
| RTPY | $9.91 | -0.30% | 11.6B | N/A | N/A | N/A |
| LVRAW | $0.04 | +0.00% | 11.5B | N/A | N/A | N/A |
| CMLFU | $13.00 | -4.55% | 10.3B | -1444.44 | -$0.01 | N/A |
| PSAC | $13.78 | -0.36% | 9.7B | N/A | N/A | N/A |
| GRSVU | $11.39 | +3.36% | 6.8B | N/A | N/A | N/A |
| APSG | $7.39 | -25.88% | 6.3B | 36.95 | $0.20 | N/A |
| RTP | $10.03 | -4.48% | 6.3B | N/A | N/A | N/A |
Stock Comparison
Lucid Group, Inc. (NYSE: CCIV)
CMLT vs CCIV Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CCIV trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CCIV's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to CCIV's ROE of -13.92%. Regarding short-term risk, CMLT is more volatile compared to CCIV. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CCIV's competition here
Property Solutions Acquisition Corp. (NASDAQ: PSACU)
CMLT vs PSACU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, PSACU has a market cap of 12B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while PSACU trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas PSACU's P/E ratio is -108.79. In terms of profitability, CMLT's ROE is N/A, compared to PSACU's ROE of -35.44%. Regarding short-term risk, CMLT is more volatile compared to PSACU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check PSACU's competition here
Reinvent Technology Partners Y (NASDAQ: RTPY)
CMLT vs RTPY Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, RTPY has a market cap of 11.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while RTPY trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas RTPY's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to RTPY's ROE of -0.43%. Regarding short-term risk, CMLT is more volatile compared to RTPY. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check RTPY's competition here
Levere Holdings Corp. (NASDAQ: LVRAW)
CMLT vs LVRAW Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, LVRAW has a market cap of 11.5B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while LVRAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas LVRAW's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to LVRAW's ROE of N/A. Regarding short-term risk, CMLT is less volatile compared to LVRAW. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check LVRAW's competition here
CM Life Sciences, Inc. (NASDAQ: CMLFU)
CMLT vs CMLFU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CMLFU has a market cap of 10.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CMLFU trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CMLFU's P/E ratio is -1444.44. In terms of profitability, CMLT's ROE is N/A, compared to CMLFU's ROE of -0.39%. Regarding short-term risk, CMLT is more volatile compared to CMLFU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CMLFU's competition here
Property Solutions Acquisition Corp. (NASDAQ: PSAC)
CMLT vs PSAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, PSAC has a market cap of 9.7B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while PSAC trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas PSAC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to PSAC's ROE of -35.44%. Regarding short-term risk, CMLT is more volatile compared to PSAC. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check PSAC's competition here
Gores Holdings V, Inc. (NASDAQ: GRSVU)
CMLT vs GRSVU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, GRSVU has a market cap of 6.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while GRSVU trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas GRSVU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to GRSVU's ROE of +0.00%. Regarding short-term risk, CMLT is more volatile compared to GRSVU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check GRSVU's competition here
Apollo Strategic Growth Capital (NYSE: APSG)
CMLT vs APSG Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, APSG has a market cap of 6.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while APSG trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas APSG's P/E ratio is 36.95. In terms of profitability, CMLT's ROE is N/A, compared to APSG's ROE of +0.03%. Regarding short-term risk, CMLT is less volatile compared to APSG. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check APSG's competition here
Reinvent Technology Partners (NYSE: RTP)
CMLT vs RTP Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, RTP has a market cap of 6.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while RTP trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas RTP's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to RTP's ROE of -0.58%. Regarding short-term risk, CMLT is more volatile compared to RTP. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check RTP's competition here
Dragoneer Growth Opportunities Corp. (NYSE: DGNR)
CMLT vs DGNR Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, DGNR has a market cap of 5.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while DGNR trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas DGNR's P/E ratio is -308.67. In terms of profitability, CMLT's ROE is N/A, compared to DGNR's ROE of +0.02%. Regarding short-term risk, CMLT is more volatile compared to DGNR. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check DGNR's competition here
VectoIQ Acquisition Corp. II (NASDAQ: VTIQ)
CMLT vs VTIQ Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, VTIQ has a market cap of 5.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while VTIQ trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas VTIQ's P/E ratio is 91.50. In terms of profitability, CMLT's ROE is N/A, compared to VTIQ's ROE of +472.81%. Regarding short-term risk, CMLT is more volatile compared to VTIQ. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check VTIQ's competition here
VectoIQ Acquisition Corp. II (NASDAQ: VTIQU)
CMLT vs VTIQU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, VTIQU has a market cap of 5.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while VTIQU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas VTIQU's P/E ratio is 100.60. In terms of profitability, CMLT's ROE is N/A, compared to VTIQU's ROE of +472.81%. Regarding short-term risk, CMLT is more volatile compared to VTIQU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check VTIQU's competition here
Vector Acquisition Corporation (NASDAQ: VACQ)
CMLT vs VACQ Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, VACQ has a market cap of 5.5B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while VACQ trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas VACQ's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to VACQ's ROE of -0.12%. Regarding short-term risk, CMLT is more volatile compared to VACQ. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check VACQ's competition here
SVF Investment Corp. 3 (NASDAQ: SVFC)
CMLT vs SVFC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SVFC has a market cap of 5.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SVFC trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SVFC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SVFC's ROE of +0.05%. Regarding short-term risk, CMLT is more volatile compared to SVFC. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check SVFC's competition here
VG Acquisition Corp. (NYSE: VGAC)
CMLT vs VGAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, VGAC has a market cap of 5B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while VGAC trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas VGAC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to VGAC's ROE of -1.21%. Regarding short-term risk, CMLT is more volatile compared to VGAC. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check VGAC's competition here
Gores Holdings VI, Inc. (NASDAQ: GHVI)
CMLT vs GHVI Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, GHVI has a market cap of 4.2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while GHVI trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas GHVI's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to GHVI's ROE of -1.28%. Regarding short-term risk, CMLT is more volatile compared to GHVI. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check GHVI's competition here
Nextdoor Holdings, Inc. (NASDAQ: KVSB)
CMLT vs KVSB Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, KVSB has a market cap of 4.2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while KVSB trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas KVSB's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to KVSB's ROE of -0.07%. Regarding short-term risk, CMLT is more volatile compared to KVSB. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check KVSB's competition here
FTAC Olympus Acquisition Corp. (NASDAQ: FTOCU)
CMLT vs FTOCU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FTOCU has a market cap of 4.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FTOCU trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FTOCU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FTOCU's ROE of +0.07%. Regarding short-term risk, CMLT is more volatile compared to FTOCU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FTOCU's competition here
Tuscan Holdings Corp. (NASDAQ: THCBU)
CMLT vs THCBU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, THCBU has a market cap of 3.9B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while THCBU trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas THCBU's P/E ratio is -101.87. In terms of profitability, CMLT's ROE is N/A, compared to THCBU's ROE of -0.23%. Regarding short-term risk, CMLT is more volatile compared to THCBU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check THCBU's competition here
Climate Change Crisis Real Impact I Acquisition Corporation (NYSE: CLII)
CMLT vs CLII Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CLII has a market cap of 3.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CLII trades at $14.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CLII's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to CLII's ROE of -0.31%. Regarding short-term risk, CMLT is more volatile compared to CLII. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CLII's competition here
GreenVision Acquisition Corp. (NASDAQ: GRNV)
CMLT vs GRNV Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, GRNV has a market cap of 3.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while GRNV trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas GRNV's P/E ratio is -59.68. In terms of profitability, CMLT's ROE is N/A, compared to GRNV's ROE of +0.05%. Regarding short-term risk, CMLT is more volatile compared to GRNV. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check GRNV's competition here
Forest Road Acquisition Corp. (NYSE: FRX)
CMLT vs FRX Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FRX has a market cap of 3.7B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FRX trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FRX's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FRX's ROE of +0.19%. Regarding short-term risk, CMLT is more volatile compared to FRX. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FRX's competition here
Holicity Inc. (NASDAQ: HOLUU)
CMLT vs HOLUU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, HOLUU has a market cap of 3.7B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while HOLUU trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas HOLUU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to HOLUU's ROE of -0.13%. Regarding short-term risk, CMLT is less volatile compared to HOLUU. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check HOLUU's competition here
Silver Spike Acquisition Corp. (NASDAQ: SSPK)
CMLT vs SSPK Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SSPK has a market cap of 3.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SSPK trades at $18.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SSPK's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SSPK's ROE of +0.04%. Regarding short-term risk, CMLT is more volatile compared to SSPK. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check SSPK's competition here
Falcon Capital Acquisition Corp. (NASDAQ: FCACU)
CMLT vs FCACU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FCACU has a market cap of 3.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FCACU trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FCACU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FCACU's ROE of -0.00%. Regarding short-term risk, CMLT is more volatile compared to FCACU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FCACU's competition here
CF Acquisition Corp. VI (NASDAQ: CFVI)
CMLT vs CFVI Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CFVI has a market cap of 3.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CFVI trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CFVI's P/E ratio is -18.55. In terms of profitability, CMLT's ROE is N/A, compared to CFVI's ROE of +0.00%. Regarding short-term risk, CMLT is more volatile compared to CFVI. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CFVI's competition here
Holicity Inc. (NASDAQ: HOL)
CMLT vs HOL Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, HOL has a market cap of 3.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while HOL trades at $12.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas HOL's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to HOL's ROE of -0.13%. Regarding short-term risk, CMLT is more volatile compared to HOL. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check HOL's competition here
Churchill Capital Corp XI Warrants (NASDAQ: CCXIW)
CMLT vs CCXIW Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CCXIW has a market cap of 3.2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CCXIW trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CCXIW's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to CCXIW's ROE of N/A. Regarding short-term risk, CMLT is more volatile compared to CCXIW. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CCXIW's competition here
Tuscan Holdings Corp. (NASDAQ: THCB)
CMLT vs THCB Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, THCB has a market cap of 3.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while THCB trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas THCB's P/E ratio is -81.30. In terms of profitability, CMLT's ROE is N/A, compared to THCB's ROE of -0.23%. Regarding short-term risk, CMLT is more volatile compared to THCB. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check THCB's competition here
Sustainable Opportunities Acquisition Corp. (NYSE: SOAC)
CMLT vs SOAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SOAC has a market cap of 2.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SOAC trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SOAC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SOAC's ROE of +3.51%. Regarding short-term risk, CMLT is more volatile compared to SOAC. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check SOAC's competition here
Decarbonization Plus Acquisition Corporation (NASDAQ: DCRBU)
CMLT vs DCRBU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, DCRBU has a market cap of 2.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while DCRBU trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas DCRBU's P/E ratio is -16.00. In terms of profitability, CMLT's ROE is N/A, compared to DCRBU's ROE of -0.84%. Regarding short-term risk, CMLT is more volatile compared to DCRBU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check DCRBU's competition here
Ivanhoe Capital Acquisition Corp. (NYSE: IVAN)
CMLT vs IVAN Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, IVAN has a market cap of 2.7B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while IVAN trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas IVAN's P/E ratio is -698.18. In terms of profitability, CMLT's ROE is N/A, compared to IVAN's ROE of -0.32%. Regarding short-term risk, CMLT is more volatile compared to IVAN. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check IVAN's competition here
Good Works Acquisition Corp. (NASDAQ: GWAC)
CMLT vs GWAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, GWAC has a market cap of 2.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while GWAC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas GWAC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to GWAC's ROE of -0.59%. Regarding short-term risk, CMLT is less volatile compared to GWAC. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check GWAC's competition here
Landcadia Holdings III, Inc (NASDAQ: LCYAU)
CMLT vs LCYAU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, LCYAU has a market cap of 2.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while LCYAU trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas LCYAU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to LCYAU's ROE of +0.04%. Regarding short-term risk, CMLT is more volatile compared to LCYAU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check LCYAU's competition here
Fifth Wall Acquisition Corp. I (NASDAQ: FWAA)
CMLT vs FWAA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FWAA has a market cap of 2.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FWAA trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FWAA's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FWAA's ROE of -0.09%. Regarding short-term risk, CMLT is more volatile compared to FWAA. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FWAA's competition here
GS Acquisition Holdings Corp II (NYSE: GSAH)
CMLT vs GSAH Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, GSAH has a market cap of 2.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while GSAH trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas GSAH's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to GSAH's ROE of +0.42%. Regarding short-term risk, CMLT is more volatile compared to GSAH. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check GSAH's competition here
Landcadia Holdings III, Inc (NASDAQ: LCY)
CMLT vs LCY Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, LCY has a market cap of 2.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while LCY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas LCY's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to LCY's ROE of +0.04%. Regarding short-term risk, CMLT is more volatile compared to LCY. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check LCY's competition here
Foresight Acquisition Corp. (NASDAQ: FORE)
CMLT vs FORE Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FORE has a market cap of 2.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FORE trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FORE's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FORE's ROE of +4.34%. Regarding short-term risk, CMLT is more volatile compared to FORE. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FORE's competition here
Revolution Acceleration Acquisition Corp (NASDAQ: RAAC)
CMLT vs RAAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, RAAC has a market cap of 2.2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while RAAC trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas RAAC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to RAAC's ROE of +0.00%. Regarding short-term risk, CMLT is more volatile compared to RAAC. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check RAAC's competition here
Supernova Partners Acquisition Company, Inc. (NYSE: SPNV)
CMLT vs SPNV Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SPNV has a market cap of 2.2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SPNV trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SPNV's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SPNV's ROE of -0.99%. Regarding short-term risk, CMLT is more volatile compared to SPNV. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check SPNV's competition here
Social Capital Suvretta Holdings Corp. III (NASDAQ: DNAC)
CMLT vs DNAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, DNAC has a market cap of 2.2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while DNAC trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas DNAC's P/E ratio is -37.72. In terms of profitability, CMLT's ROE is N/A, compared to DNAC's ROE of -0.34%. Regarding short-term risk, CMLT is less volatile compared to DNAC. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check DNAC's competition here
Fortress Value Acquisition Corp. II (NYSE: FAII)
CMLT vs FAII Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FAII has a market cap of 2.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FAII trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FAII's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FAII's ROE of -0.32%. Regarding short-term risk, CMLT is more volatile compared to FAII. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FAII's competition here
dMY Technology Group, Inc. III (NYSE: DMYI)
CMLT vs DMYI Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, DMYI has a market cap of 2.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while DMYI trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas DMYI's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to DMYI's ROE of -0.16%. Regarding short-term risk, CMLT is less volatile compared to DMYI. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check DMYI's competition here
Live Oak Acquisition Corp. II (NYSE: LOKB)
CMLT vs LOKB Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, LOKB has a market cap of 2.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while LOKB trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas LOKB's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to LOKB's ROE of -0.62%. Regarding short-term risk, CMLT is more volatile compared to LOKB. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check LOKB's competition here
Star Peak Corp II (NYSE: STPC)
CMLT vs STPC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, STPC has a market cap of 2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while STPC trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas STPC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to STPC's ROE of -0.29%. Regarding short-term risk, CMLT is more volatile compared to STPC. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check STPC's competition here
Mudrick Capital Acquisition Corporation II (NASDAQ: MUDS)
CMLT vs MUDS Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, MUDS has a market cap of 2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while MUDS trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas MUDS's P/E ratio is 3.39. In terms of profitability, CMLT's ROE is N/A, compared to MUDS's ROE of -0.01%. Regarding short-term risk, CMLT is more volatile compared to MUDS. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check MUDS's competition here
Mudrick Capital Acquisition Corporation II (NASDAQ: MUDSU)
CMLT vs MUDSU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, MUDSU has a market cap of 2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while MUDSU trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas MUDSU's P/E ratio is -1125.56. In terms of profitability, CMLT's ROE is N/A, compared to MUDSU's ROE of -0.01%. Regarding short-term risk, CMLT is more volatile compared to MUDSU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check MUDSU's competition here
Tiga Acquisition Corp. (NYSE: TINV)
CMLT vs TINV Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, TINV has a market cap of 2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while TINV trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas TINV's P/E ratio is 30.61. In terms of profitability, CMLT's ROE is N/A, compared to TINV's ROE of +1.23%. Regarding short-term risk, CMLT is less volatile compared to TINV. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check TINV's competition here
Apex Treasury Corporation Class A (NASDAQ: APXT)
CMLT vs APXT Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, APXT has a market cap of 1.9B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while APXT trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas APXT's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to APXT's ROE of +0.16%. Regarding short-term risk, CMLT is more volatile compared to APXT. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check APXT's competition here
Apex Treasury Corporation (NASDAQ: APXTU)
CMLT vs APXTU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, APXTU has a market cap of 1.9B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while APXTU trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas APXTU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to APXTU's ROE of +0.16%. Regarding short-term risk, CMLT is more volatile compared to APXTU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check APXTU's competition here
Digital World Acquisition Corp. (NASDAQ: DWAC)
CMLT vs DWAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, DWAC has a market cap of 1.9B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while DWAC trades at $49.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas DWAC's P/E ratio is -73.46. In terms of profitability, CMLT's ROE is N/A, compared to DWAC's ROE of -0.58%. Regarding short-term risk, CMLT is less volatile compared to DWAC. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check DWAC's competition here
Digital World Acquisition Corp. (NASDAQ: DWACU)
CMLT vs DWACU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, DWACU has a market cap of 1.9B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while DWACU trades at $61.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas DWACU's P/E ratio is -451.10. In terms of profitability, CMLT's ROE is N/A, compared to DWACU's ROE of -0.58%. Regarding short-term risk, CMLT is less volatile compared to DWACU. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check DWACU's competition here
Athena Technology Acquisition Corp. (NYSE: ATHN)
CMLT vs ATHN Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, ATHN has a market cap of 1.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while ATHN trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas ATHN's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to ATHN's ROE of +2.24%. Regarding short-term risk, CMLT is less volatile compared to ATHN. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check ATHN's competition here
Apex Treasury Corporation (NASDAQ: APXTW)
CMLT vs APXTW Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, APXTW has a market cap of 1.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while APXTW trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas APXTW's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to APXTW's ROE of +0.16%. Regarding short-term risk, CMLT is more volatile compared to APXTW. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check APXTW's competition here
Gores Metropoulos II, Inc. (NASDAQ: GMII)
CMLT vs GMII Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, GMII has a market cap of 1.8B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while GMII trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas GMII's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to GMII's ROE of +0.21%. Regarding short-term risk, CMLT is more volatile compared to GMII. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check GMII's competition here
Motive Capital Corp. (NYSE: MOTV)
CMLT vs MOTV Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, MOTV has a market cap of 1.7B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while MOTV trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas MOTV's P/E ratio is 55.86. In terms of profitability, CMLT's ROE is N/A, compared to MOTV's ROE of -0.23%. Regarding short-term risk, CMLT is more volatile compared to MOTV. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check MOTV's competition here
CBRE Acquisition Holdings, Inc. (NYSE: CBAH)
CMLT vs CBAH Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CBAH has a market cap of 1.7B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CBAH trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CBAH's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to CBAH's ROE of +0.04%. Regarding short-term risk, CMLT is more volatile compared to CBAH. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CBAH's competition here
GX Acquisition Corp. (NASDAQ: GXGXU)
CMLT vs GXGXU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, GXGXU has a market cap of 1.7B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while GXGXU trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas GXGXU's P/E ratio is -23.73. In terms of profitability, CMLT's ROE is N/A, compared to GXGXU's ROE of -0.03%. Regarding short-term risk, CMLT is less volatile compared to GXGXU. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check GXGXU's competition here
One (NYSE: AONE)
CMLT vs AONE Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, AONE has a market cap of 1.7B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while AONE trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas AONE's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to AONE's ROE of -17.11%. Regarding short-term risk, CMLT is less volatile compared to AONE. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check AONE's competition here
Tortoise Acquisition Corp. II (NYSE: SNPR)
CMLT vs SNPR Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SNPR has a market cap of 1.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SNPR trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SNPR's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SNPR's ROE of +0.00%. Regarding short-term risk, CMLT is less volatile compared to SNPR. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check SNPR's competition here
Jaws Spitfire Acquisition Corporation (NYSE: SPFR)
CMLT vs SPFR Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SPFR has a market cap of 1.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SPFR trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SPFR's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SPFR's ROE of -4.58%. Regarding short-term risk, CMLT is less volatile compared to SPFR. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check SPFR's competition here
D8 Holdings Corp. (NYSE: DEH)
CMLT vs DEH Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, DEH has a market cap of 1.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while DEH trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas DEH's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to DEH's ROE of -3.33%. Regarding short-term risk, CMLT is more volatile compared to DEH. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check DEH's competition here
Rotor Acquisition Corp. (NYSE: ROT)
CMLT vs ROT Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, ROT has a market cap of 1.6B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while ROT trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas ROT's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to ROT's ROE of -0.45%. Regarding short-term risk, CMLT is more volatile compared to ROT. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check ROT's competition here
NextGen Acquisition Corporation (NASDAQ: NGAC)
CMLT vs NGAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, NGAC has a market cap of 1.5B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while NGAC trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas NGAC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to NGAC's ROE of -0.87%. Regarding short-term risk, CMLT is more volatile compared to NGAC. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check NGAC's competition here
Celularity Inc. (NASDAQ: GXGX)
CMLT vs GXGX Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, GXGX has a market cap of 1.5B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while GXGX trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas GXGX's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to GXGX's ROE of +4.12%. Regarding short-term risk, CMLT is less volatile compared to GXGX. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check GXGX's competition here
Hudson Executive Investment Corp. (NASDAQ: HECCU)
CMLT vs HECCU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, HECCU has a market cap of 1.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while HECCU trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas HECCU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to HECCU's ROE of -0.10%. Regarding short-term risk, CMLT is more volatile compared to HECCU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check HECCU's competition here
Altimar Acquisition Corp. II (NYSE: ATMR)
CMLT vs ATMR Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, ATMR has a market cap of 1.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while ATMR trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas ATMR's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to ATMR's ROE of +0.44%. Regarding short-term risk, CMLT is less volatile compared to ATMR. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check ATMR's competition here
Osprey Technology Acquisition Corp. (NYSE: SFTW)
CMLT vs SFTW Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SFTW has a market cap of 1.4B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SFTW trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SFTW's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SFTW's ROE of -0.56%. Regarding short-term risk, CMLT is less volatile compared to SFTW. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check SFTW's competition here
890 5th Avenue Partners, Inc. (NASDAQ: ENFA)
CMLT vs ENFA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, ENFA has a market cap of 1.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while ENFA trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas ENFA's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to ENFA's ROE of -1.15%. Regarding short-term risk, CMLT is less volatile compared to ENFA. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check ENFA's competition here
Environmental Impact Acquisition Corp. (NASDAQ: ENVI)
CMLT vs ENVI Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, ENVI has a market cap of 1.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while ENVI trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas ENVI's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to ENVI's ROE of +0.00%. Regarding short-term risk, CMLT is more volatile compared to ENVI. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check ENVI's competition here
ArcLight Clean Transition Corp. II (NASDAQ: ACTD)
CMLT vs ACTD Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, ACTD has a market cap of 1.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while ACTD trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas ACTD's P/E ratio is -25.50. In terms of profitability, CMLT's ROE is N/A, compared to ACTD's ROE of +0.00%. Regarding short-term risk, CMLT is less volatile compared to ACTD. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check ACTD's competition here
Vickers Vantage Corp. I (NASDAQ: VCKA)
CMLT vs VCKA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, VCKA has a market cap of 1.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while VCKA trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas VCKA's P/E ratio is 100.11. In terms of profitability, CMLT's ROE is N/A, compared to VCKA's ROE of +1.68%. Regarding short-term risk, CMLT is less volatile compared to VCKA. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check VCKA's competition here
Thimble Point Acquisition Corp. (NASDAQ: THMA)
CMLT vs THMA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, THMA has a market cap of 1.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while THMA trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas THMA's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to THMA's ROE of +0.00%. Regarding short-term risk, CMLT is more volatile compared to THMA. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check THMA's competition here
L&F Acquisition Corp. (NYSE: LNFA)
CMLT vs LNFA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, LNFA has a market cap of 1.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while LNFA trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas LNFA's P/E ratio is 21.06. In terms of profitability, CMLT's ROE is N/A, compared to LNFA's ROE of +0.09%. Regarding short-term risk, CMLT is less volatile compared to LNFA. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check LNFA's competition here
Fintech Acquisition Corp. IV (NASDAQ: FTIVU)
CMLT vs FTIVU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FTIVU has a market cap of 1.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FTIVU trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FTIVU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FTIVU's ROE of -0.14%. Regarding short-term risk, CMLT is more volatile compared to FTIVU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FTIVU's competition here
ACON S2 Acquisition Corp. (NASDAQ: STWO)
CMLT vs STWO Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, STWO has a market cap of 1.3B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while STWO trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas STWO's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to STWO's ROE of +0.00%. Regarding short-term risk, CMLT is more volatile compared to STWO. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check STWO's competition here
Haymaker Acquisition Corp. III (NASDAQ: HYACU)
CMLT vs HYACU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, HYACU has a market cap of 1.2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while HYACU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas HYACU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to HYACU's ROE of -0.11%. Regarding short-term risk, CMLT is more volatile compared to HYACU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check HYACU's competition here
Fintech Acquisition Corp. IV (NASDAQ: FTIV)
CMLT vs FTIV Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FTIV has a market cap of 1.2B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FTIV trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FTIV's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FTIV's ROE of -0.14%. Regarding short-term risk, CMLT is more volatile compared to FTIV. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FTIV's competition here
Alpha Healthcare Acquisition Corp. (NASDAQ: AHAC)
CMLT vs AHAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, AHAC has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while AHAC trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas AHAC's P/E ratio is -72.11. In terms of profitability, CMLT's ROE is N/A, compared to AHAC's ROE of -16.18%. Regarding short-term risk, CMLT is less volatile compared to AHAC. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check AHAC's competition here
Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC)
CMLT vs AMHC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, AMHC has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while AMHC trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas AMHC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to AMHC's ROE of +0.00%. Regarding short-term risk, CMLT is less volatile compared to AMHC. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check AMHC's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERA)
CMLT vs HERA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, HERA has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while HERA trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas HERA's P/E ratio is 46.32. In terms of profitability, CMLT's ROE is N/A, compared to HERA's ROE of +0.01%. Regarding short-term risk, CMLT is more volatile compared to HERA. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check HERA's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERAW)
CMLT vs HERAW Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, HERAW has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while HERAW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas HERAW's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to HERAW's ROE of +0.01%. Regarding short-term risk, CMLT is less volatile compared to HERAW. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check HERAW's competition here
FG New America Acquisition Corp. (NYSE: FGNA)
CMLT vs FGNA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FGNA has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FGNA trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FGNA's P/E ratio is -4.35. In terms of profitability, CMLT's ROE is N/A, compared to FGNA's ROE of +0.71%. Regarding short-term risk, CMLT is more volatile compared to FGNA. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FGNA's competition here
Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA)
CMLT vs DNAA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, DNAA has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while DNAA trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas DNAA's P/E ratio is -54.53. In terms of profitability, CMLT's ROE is N/A, compared to DNAA's ROE of +0.00%. Regarding short-term risk, CMLT is less volatile compared to DNAA. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check DNAA's competition here
Therapeutics Acquisition Corp. (NASDAQ: RACA)
CMLT vs RACA Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, RACA has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while RACA trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas RACA's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to RACA's ROE of +0.00%. Regarding short-term risk, CMLT is more volatile compared to RACA. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check RACA's competition here
Trebia Acquisition Corp. (NYSE: TREB)
CMLT vs TREB Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, TREB has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while TREB trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas TREB's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to TREB's ROE of -12.26%. Regarding short-term risk, CMLT is less volatile compared to TREB. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check TREB's competition here
TPG Pace Tech Opportunities Corp. (NYSE: PACE)
CMLT vs PACE Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, PACE has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while PACE trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas PACE's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to PACE's ROE of -1.52%. Regarding short-term risk, CMLT is more volatile compared to PACE. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check PACE's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERAU)
CMLT vs HERAU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, HERAU has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while HERAU trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas HERAU's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to HERAU's ROE of +0.01%. Regarding short-term risk, CMLT is more volatile compared to HERAU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check HERAU's competition here
LifeSci Acquisition II Corp. (NASDAQ: LSAQ)
CMLT vs LSAQ Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, LSAQ has a market cap of 1.1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while LSAQ trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas LSAQ's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to LSAQ's ROE of N/A. Regarding short-term risk, CMLT is more volatile compared to LSAQ. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check LSAQ's competition here
Stable Road Acquisition Corp. (NASDAQ: SRAC)
CMLT vs SRAC Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SRAC has a market cap of 1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SRAC trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SRAC's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SRAC's ROE of -4.03%. Regarding short-term risk, CMLT is more volatile compared to SRAC. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check SRAC's competition here
FTAC Parnassus Acquisition Corp. (NASDAQ: FTPAW)
CMLT vs FTPAW Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, FTPAW has a market cap of 1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while FTPAW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas FTPAW's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to FTPAW's ROE of -0.00%. Regarding short-term risk, CMLT is more volatile compared to FTPAW. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check FTPAW's competition here
Sandbridge Acquisition Corporation (NYSE: SBG)
CMLT vs SBG Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, SBG has a market cap of 1B. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while SBG trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas SBG's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to SBG's ROE of -3.15%. Regarding short-term risk, CMLT is more volatile compared to SBG. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check SBG's competition here
Churchill Capital Corp VII (NYSE: CVII-WT)
CMLT vs CVII-WT Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CVII-WT has a market cap of 977.9M. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CVII-WT trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CVII-WT's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to CVII-WT's ROE of +0.02%. Regarding short-term risk, CMLT is more volatile compared to CVII-WT. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CVII-WT's competition here
Bleichroeder Acquisition Corp. II (NASDAQ: BBCQW)
CMLT vs BBCQW Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, BBCQW has a market cap of 977.6M. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while BBCQW trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas BBCQW's P/E ratio is N/A. In terms of profitability, CMLT's ROE is N/A, compared to BBCQW's ROE of N/A. Regarding short-term risk, CMLT is more volatile compared to BBCQW. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check BBCQW's competition here
Churchill Capital Corp VII (NYSE: CVII-UN)
CMLT vs CVII-UN Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CVII-UN has a market cap of 958.8M. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CVII-UN trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CVII-UN's P/E ratio is 64.65. In terms of profitability, CMLT's ROE is N/A, compared to CVII-UN's ROE of +0.02%. Regarding short-term risk, CMLT is less volatile compared to CVII-UN. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check CVII-UN's competition here
B. Riley Principal 150 Merger Corp. (NASDAQ: BRPM)
CMLT vs BRPM Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, BRPM has a market cap of 944M. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while BRPM trades at $13.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas BRPM's P/E ratio is -72.74. In terms of profitability, CMLT's ROE is N/A, compared to BRPM's ROE of +4.56%. Regarding short-term risk, CMLT is less volatile compared to BRPM. This indicates lower risk in terms of short-term price fluctuations for CMLT.Check BRPM's competition here
Crescent Acquisition Corp. (NASDAQ: CRSAU)
CMLT vs CRSAU Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CRSAU has a market cap of 937.8M. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CRSAU trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CRSAU's P/E ratio is -27.21. In terms of profitability, CMLT's ROE is N/A, compared to CRSAU's ROE of -0.34%. Regarding short-term risk, CMLT is more volatile compared to CRSAU. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CRSAU's competition here
Churchill Capital Corp VII (NYSE: CVII)
CMLT vs CVII Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, CVII has a market cap of 914.7M. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while CVII trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas CVII's P/E ratio is 999.00. In terms of profitability, CMLT's ROE is N/A, compared to CVII's ROE of +0.02%. Regarding short-term risk, CMLT is more volatile compared to CVII. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check CVII's competition here
BCTG Acquisition Corp. (NASDAQ: BCTG)
CMLT vs BCTG Comparison August 2026
CM Life Sciences III Inc. (NASDAQ: CMLT) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CMLT stands at 4.2B. In comparison, BCTG has a market cap of 899.4M. Regarding current trading prices, CMLT is priced at $8.69 on the NASDAQ, while BCTG trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CMLT currently has a P/E ratio of N/A, whereas BCTG's P/E ratio is -204.00. In terms of profitability, CMLT's ROE is N/A, compared to BCTG's ROE of -0.42%. Regarding short-term risk, CMLT is more volatile compared to BCTG. This indicates higher risk in terms of short-term price fluctuations for CMLT.Check BCTG's competition here